Pascale N Lacor

Title: Pascale N Lacor: Innovator in Monoclonal Antibodies

Introduction

Pascale N Lacor is a notable inventor based in Chicago, IL (US). She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies that target pathological assemblies of amyloid beta (Abeta). Her work is crucial in understanding and potentially treating Alzheimer's Disease.

Latest Patents

Pascale N Lacor holds 1 patent for her innovative work on monoclonal antibodies. The patent discloses antibodies that bind with high specificity to soluble oligomers of amyloid beta. These antibodies are designed to distinguish between Alzheimer's Disease and control human brain extracts. They identify endogenous Abeta oligomers in Alzheimer's brain slices and bind to Abeta oligomers on cultured hippocampal cells. Furthermore, these antibodies have the ability to neutralize endogenous Abeta oligomers and those produced in solution.

Career Highlights

Throughout her career, Pascale has worked with prominent organizations such as Acumen Pharmaceuticals, Inc. and Northwestern University. Her research has significantly advanced the understanding of Alzheimer's Disease and the role of amyloid beta in its pathology.

Collaborations

Pascale has collaborated with esteemed colleagues, including Lei Chang and William L Klein. These partnerships have further enriched her research and contributed to the development of her innovative antibodies.

Conclusion

Pascale N Lacor's work in the field of monoclonal antibodies represents a significant advancement in Alzheimer's research. Her innovative approach and dedication to understanding amyloid beta pathology highlight her importance as an inventor in the biomedical field.